Aeolus Pharmaceuticals Inc

BioCryst Pharmaceuticals designs, optimizes and develops novel small-molecule drugs that treat cancer, cardiovascular and autoimmune diseases and viral infections. BioCryst uses structure-based drug design, which incorporates multiple scientific disciplines, including biology, crystallography, medicinal chemistry and computer modeling. In structure-based drug design, scientists use detailed knowledge of the active sites of protein targets associated with particular diseases to design synthetic compounds that fight the disease. Structure-based drug design aims to create a molecule that will bind to the active site of a targeted enzyme, thereby preventing the normal chemical reaction and ultimately halting the progression of the disease. BioCryst was founded in 1986. The Company's stock is traded on the NASDAQ exchange under the symbol BCRX.

Synthon Ind is a leading pharmaceutical company based in Morrisville, NC, specializing in the development, manufacturing, and commercialization of complex generic pharmaceuticals globally. With a legacy of over three decades in the industry, Synthon is known for its innovative approach, scientific rigor, and commitment to providing safe and affordable medicines. Driven by a strong focus on research and development, Synthon offers a diverse portfolio of high-quality generic products across various therapy areas and dosage forms. Their global presence and reliable manufacturing network ensure a consistent supply of products to meet the needs of partners and customers worldwide.Generated from the website

Nuada Pharmaceuticals is a biopharmaceutical company based in Durham, NC, specializing in the development of innovative medical treatments. With a focus on research and development, Nuada Pharmaceuticals aims to address unmet medical needs and improve patient outcomes through cutting-edge therapies. Generated from their business information